Nutent Therapeutics’ pharmaceutical grade curcumin is statistically proven to work better than standalone turmeric extracts

VOLT03: Pharma-Grade Curcumin

Our mission is to develop and market Nutraceuticals as Pharmaceutical grade with pre-clinical and
clinical data to support its superior therapeutic value in patients.

MORE INFO


turmeric root

Volt.03 Logo

Introducing VOLT03

The pharmaceutical answer to Curcumin. Superior anti-inflammatory properties over regular curcumin as well as improved bioavailability.

See why currently VOLT03 is the best curcumin supplement on the market.

READ MOREGO TO SHOP


Nutent Therapeutics

Pipeline

Nutent Therapeutics pipeline is comprised of VOLT03, a pharmaceutical-grade complexed curcumin with superior absorption and bioavailability.

Sick Woman

Problem

Evidence from numerous literatures revealed that curcumin has poor absorption.
Read More

Woman Smiling

Solution

Cyclodextrin has been used to improve curcumin’s delivery and bioavailability
Read More

The Curative Properties of Curcumin

Volt03

VOLT03 is the only pharmaceutical-grade curcumin and the only product
Read More

pipeline4a

Publications

Pharma-grade will allow for international distribution, into the prescription market.
Read More



Chief Executive Officer

Richard P. Becker Jr, R.Ph., M.B.A.

Mr. Becker was appointed to his current position in January, 2017 and has more than 20 years of experience in the pharmaceutical and biotechnology industry. Mr. Becker has successfully led large, medium and entrepreneurial companies to substantial growth in fiercely competitive markets. He is currently the CEO of Levolta Pharmaceuticals, a clinical-stage company with a phase III product targeting knee osteoarthritis.

VIEW PROFILECONTACT NOW


RICHARD P. BECKER JR, R.PH., M.B.A.

CALL US NOW 561-208-3033


Overview

DISTRIBUTORS &
BUSINESS PARTNERS

Nutent Therapeutics is committed to strategic growth through targeted product acquisitions and partnerships.

We are actively pursuing external opportunities including in-licensing, out-licensing, co-development and co-marketing that are aligned with our internal areas of expertise and offer significant customer value.


Our Partners


COMING SOON



Nutent Therapeutics will commercialize pharmaceutical-grade products that will be differentiated through successful clinical trials across multiple therapeutic areas.

Our Contact

3651 FAU Boulevard Suite 400 Boca Raton FL 33431 United States

Phone : 561-208-3033

rbecker@nutenttherapeutics.com

Top